The cumulative lifetime risk of BRCA1 mutation carriers is up to 85 % for BC and 20-40 % for OC, whereas BRCA2 mutations carriers have somewhat lesser risk for BC (45-84 %) and a risk up to 31 % for OC [7–11]. This evidence concerns the gene BRCA2 and breast cancer.